Vanda Pharmaceuticals (VNDA) Profit After Tax Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -156.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -156.80% |
| Dec 31, 2025 | -182.64% |
| Sep 30, 2025 | -107.29% |
| Jun 30, 2025 | -132.51% |
| Mar 31, 2025 | -66.15% |
| Dec 31, 2024 | -39.14% |
| Sep 30, 2024 | -38.99% |
| Jun 30, 2024 | -35.14% |
| Mar 31, 2024 | -35.35% |
| Dec 31, 2023 | -31.87% |
| Sep 30, 2023 | -71.55% |
| Jun 30, 2023 | -44.13% |
| Mar 31, 2023 | 88.44% |
| Dec 31, 2022 | 17.62% |
| Sep 30, 2022 | -68.07% |
| Jun 30, 2022 | -39.33% |
| Mar 31, 2022 | -119.02% |
| Dec 31, 2021 | -11.93% |
| Sep 30, 2021 | 2.71% |
| Jun 30, 2021 | 27.93% |
| Mar 31, 2021 | 41.30% |
| Dec 31, 2020 | 86.20% |
| Sep 30, 2020 | 48.99% |
| Jun 30, 2020 | 97.30% |
| Mar 31, 2020 | 27.31% |
| Dec 31, 2019 | 107.86% |
| Sep 30, 2019 | 517.57% |
| Jun 30, 2019 | 65.05% |
| Mar 31, 2019 | 63.28% |
| Dec 31, 2018 | 39.25% |
| Sep 30, 2018 | 40.24% |
| Jun 30, 2018 | 41.88% |
| Mar 31, 2018 | 32.00% |
| Dec 31, 2017 | -26.54% |
| Sep 30, 2017 | -47.22% |
| Jun 30, 2017 | 58.57% |
| Mar 31, 2017 | 33.95% |
| Dec 31, 2016 | 57.28% |
| Sep 30, 2016 | 56.99% |
| Jun 30, 2016 | -10.93% |
| Mar 31, 2016 | -39.84% |
| Dec 31, 2015 | -32.44% |
| Sep 30, 2015 | -21.11% |
| Jun 30, 2015 | 12.38% |
| Mar 31, 2015 | -8.68% |
| Dec 31, 2014 | 144.54% |
| Sep 30, 2014 | 22.59% |
| Jun 30, 2014 | -152.45% |
| Mar 31, 2014 | -481.96% |
| Dec 31, 2013 | -76.76% |
| Sep 30, 2013 | -54.64% |
| Jun 30, 2013 | -66.83% |